What is the recommended Q‑fever vaccination regimen for humans and livestock?

Q fever vaccine regimen (humans and livestock)

• Bold Recommendation
  • Use Q‑VAX (Australia only) as a single subcutaneous dose for at‑risk adults after mandatory pre‑vaccination screening; for livestock, vaccinate sheep/goats/cattle with an inactivated phase I Coxiella burnetii vaccine per-label (prime early, before first pregnancy) to reduce abortions and shedding, thereby lowering human morbidity, mortality, and QOL harm. 1, 2

Humans (priority: prevent severe chronic Q fever/endocarditis)

• Availability and indication
  • No licensed human vaccine in the U.S.; a licensed vaccine (Q‑VAX) is available in Australia for high‑risk workers (abattoirs, veterinarians, farmers, lab animal facilities) 1.
• Regimen (Australia)
  • Single 0.5 mL subcutaneous dose of inactivated phase I whole‑cell C. burnetii (Q‑VAX), given only if pre‑screen negative (skin test and serology) to avoid severe hypersensitivity reactions; protection durable for ≥5 years and highly effective in outbreak settings 3, 4, 5.
• Pre‑vaccination screening (critical pitfall to avoid)
  • Required: intradermal skin test with C. burnetii antigen plus serology (phase I/II IgG); any evidence of prior exposure contraindicates vaccination due to reactogenicity risk 4, 5.
• Who should be prioritized (highest impact on morbidity/mortality/QOL)
  • At‑risk workers, especially with valvulopathy, prosthetic valves/grafts/aneurysms, pregnancy potential, or immunosuppression—because chronic Q fever endocarditis is fatal if untreated 1.
• U.S./non‑Australia settings
  • No vaccine; rely on exposure reduction (respiratory protection during high‑risk tasks, on‑site laundering, biosecurity) and rapid diagnosis/treatment; do not use antibiotic post‑exposure prophylaxis routinely 1.

Livestock (reduce animal disease and human spillover)

• Vaccine and targets
  • Use inactivated phase I C. burnetii vaccines approved for sheep, goats, and cattle; vaccinate entire at‑risk herds, especially small ruminants linked to human outbreaks 2, 6.
• Regimen and timing
  • Prime before first breeding/first pregnancy (ideally pre‑puberty or as early as label allows); in infected herds, mass vaccinate as soon as feasible; follow label for booster schedules (some programs boost annually or per manufacturer) 2, 6.
• Expected outcomes (evidence synthesis)
  • Consistent reduction in abortions and improved reproduction; decreased shedding intensity and duration, which lowers environmental contamination and human risk; generally well tolerated with mild, transient effects (e.g., fever, temporary milk drop) 2.
• Programmatic essentials
  • Combine vaccination with strict periparturient hygiene, immediate removal/disposal of birth products, manure management, controlled animal movements, and targeted surveillance; these steps are necessary because testing cannot reliably confirm non‑shedding status and shedding is intermittent 1, 6.

Practical algorithm

• Humans (Australia)
  • At‑risk adult → Perform C. burnetii skin test + serology
    • Both negative → Give single SC Q‑VAX dose → No routine boosters unless per local guidance 3, 4.
    • Any positive → Do not vaccinate; educate, implement exposure controls 4.
• Humans (U.S./elsewhere without vaccine)
  • At‑risk adult → No vaccine available → Enforce PPE (N95 during high‑risk tasks), on‑site laundering, airflow controls; no routine antibiotic PEP; prompt testing/treatment if symptomatic 1.
• Livestock (sheep/goats/cattle)
  • Herd without vaccination history → Vaccinate all eligible animals with inactivated phase I vaccine before breeding; implement biosecurity and hygiene; follow label for boosters 2.
  • Herd with suspected/confirmed infection or human outbreak → Mass vaccinate ASAP + strict periparturient controls and environmental management; continue surveillance 2, 6.

Key pitfalls and how to avoid them

• Vaccinating previously exposed humans with Q‑VAX without screening → high risk of severe local/systemic reactions; always do skin test + serology first 4, 5.
• Delaying livestock vaccination until or after pregnancy → less impact on abortions and shedding; vaccinate before first pregnancy 2.
• Relying on animal serology/PCR alone to declare herds “safe” → shedding is intermittent; maintain vaccination, hygiene, and movement controls regardless of single negative tests 1.
• Using antibiotic post‑exposure prophylaxis in workers → not supported; focus on prevention and early treatment if symptomatic 1.

Why this protects morbidity, mortality, QOL

• Prevents human chronic Q fever endocarditis (fatal if untreated) by cutting exposure at the source (livestock) and by vaccinating high‑risk workers where available; reduces debilitating acute disease and long‑term QOL impacts 1, 2.